U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538570) titled 'Evaluation of Pain Treatment After Total Knee Arthroplasty' on April 13.
Brief Summary: The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
Pain
Intervention:
DRUG: Suzetrigine
Tablets for oral administration.
DRUG: Placebo
Placebo matched to SUZ for oral administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vertex Pharmaceuticals Incorporated
Published by HT Digital Content Services with permission from Health Daily Digest....